FDA issues recommendations to reduce the risk of Zika virus transmission by human cell and tissue products - FDA Press Releases

As an additional safety measure against the emerging Zika virus outbreak, the U.S. Food and Drug Administration today issued new guidance for immediate implementation providing recommendations to reduce the potential transmission risk of Zika virus from human cells, tissues, and cellular and tissue-based products (HCT/Ps). The guidance addresses donation of HCT/Ps from both living and deceased donors, including donors of umbilical cord blood, placenta, or other gestational tissues.

from Food and Drug Administration--Press Releases http://ift.tt/1oN9G1l
via IFTTT